CD14

CD14 詳細

英語名Monocyte differentiation antigen CD14市販薬剤の数0
治験薬の数3ターゲットの別称CD14,CD14 Molecule,Myeloid Cell-Specific Leucine-Rich Glycoprotein,CD14 Antigen,Monocyte Differentiation Antigen CD14
研究&開発段階Phase 2 Clinical
英語名Monocyte differentiation antigen CD14
ターゲットの別称CD14,CD14 Molecule,Myeloid Cell-Specific Leucine-Rich Glycoprotein,CD14 Antigen,Monocyte Differentiation Antigen CD14
市販薬剤の数0
治験薬の数3
研究&開発段階Phase 2 Clinical

CD14 製品リスト

  • 属性

    Protein (3)Cell Grade Beads (1)Antibody (2)

  • 製品ライブラリ

    オンライン (6)

  • Human (4)Mouse (2)

  • タグ

    His Tag (1)Fc Tag (1)His Tag & Avi Tag (1)- (3)

  • マーカー

    Unconjugated (2)Biotin-labeled (1)- (1)PE Labeled (1)APC Labeled (1)

CD14バックグランド

Cluster of differentiation 14 (CD14), is a cell surface glycoprotein, and is a is a component of the innate immune system. CD14 is a myelomonocytic differentiation antigen preferentially expressed on monocytes, macrophages, and activated granulocytes. CD14 exists in two forms. Either it is anchored into the membrane by a glycosylphosphatidylinositol tail (mCD14) or it appears in a soluble form (sCD14). Soluble CD14 either appears after shedding of mCD14 (48 kDa) or is directly secreted from intracellular vesicles (56 kDa). CD14 acts as a co-receptor (along with the Toll-like receptor TLR 4 and MD-2) for the detection of bacterial lipopolysaccharide (LPS). CD14 can bind LPS only in the presence of lipopolysaccharide-binding protein (LBP). CD14 has been proposed to be involved in various biological processes, including transportation of other lipids, cell-cell interaction during different immune responses, as well as recognition of apoptotic cells. Although LPS is considered its main ligand, CD14 also recognizes other pathogen-associated molecular patterns. CD14+ cells are monocytes that can differentiate into a host of different cells. CD14 has been shown to interact with Lipopolysaccharide-binding protein.

CD14分子の別称

CD14

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AtibuclimabIC-14Phase 2 ClinicalIcos CorporationAcute Lung Injury; Acutely decompensated congestive heart failure; Amyotrophic Lateral Sclerosis; Arrhythmias, Cardiac; Arrhythmogenic Right Ventricular Dysplasia; Cardiomyopathies; Coronavirus Disease 2019 (COVID-19); Dengue; Lung Diseases; Motor Neuron Disease; Pneumonia; Respiratory Distress Syndrome, Adult; Sepsis; ST Elevation Myocardial Infarction
詳細
VB-201CI-201; VB-201Phase 2 ClinicalNotable Labs LtdCardiovascular Diseases; Colitis, Ulcerative; Coronavirus Disease 2019 (COVID-19); HIV Infections; Inflammation; Plaque psoriasis; Psoriasis
詳細
TCP-25TCP-25Phase 2 ClinicalLund UniversityBlister; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa, Junctional; Wounds and Injuries
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8